U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07441499) titled 'Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma' on Jan. 20.
Brief Summary: Application of Multi-Component Liquid Biopsy (ctDNA, utDNA, Exosomes, and Protein Biomarkers in Blood and Urine) for Auxiliary Diagnosis, Therapeutic Response Evaluation, and Recurrence Monitoring in Urothelial Carcinoma
Study Start Date: March, 2026
Study Type: OBSERVATIONAL
Condition:
Urothelial Carcinoma (UC)
Bladder (Urothelial, Transitional Cell) Cancer
Liquid Biopsy
Intervention:
DIAGNOSTIC_TEST: Multi-Component Liquid Biopsy for Urothelial Carcinoma
This intervention is a non-invasive, multi-componen...